Sumitomo Life Insurance’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
16,037
+439
+3% +$33.8K 0.03% 172
2025
Q4
$1.24M Buy
15,598
+102
+0.7% +$8.04K 0.03% 167
2025
Q3
$1.17M Sell
15,496
-467
-3% -$32K 0.04% 171
2025
Q2
$1.1M Sell
15,963
-1,151
-7% -$75.5K 0.07% 169
2025
Q1
$1.16M Buy
17,114
+174
+1% +$10.4K 0.04% 171
2024
Q4
$760K Sell
16,940
-752
-4% -$42.2K 0.01% 213
2024
Q3
$1.11M Buy
17,692
+516
+3% +$30.1K 0.02% 183
2024
Q2
$1.01M Sell
17,176
-2,199
-11% -$138K 0.02% 179
2024
Q1
$1.55M Sell
19,375
-763
-4% -$58.3K 0.04% 145
2023
Q4
$1.59M Sell
20,138
-1,044
-5% -$74.3K 0.05% 142
2023
Q3
$1.48M Sell
21,182
-275
-1% -$19.5K 0.04% 128
2023
Q2
$1.48M Sell
21,457
-2,082
-9% -$148K 0.07% 135
2023
Q1
$1.75M Sell
23,539
-173
-0.7% -$14.5K 0.15% 111
2022
Q4
$2.21M Sell
23,712
-216
-0.9% -$20.8K 0.16% 74
2022
Q3
$2.28M Sell
23,928
-2,925
-11% -$290K 0.1% 64
2022
Q2
$2.49M Buy
26,853
+529
+2% +$51.6K 0.07% 73
2022
Q1
$2.66M Sell
26,324
-421
-2% -$44.2K 0.07% 81
2021
Q4
$2.76M Sell
26,745
-790
-3% -$73K 0.07% 85
2021
Q3
$2.34M Sell
27,535
-1,164
-4% -$97.5K 0.06% 98
2021
Q2
$2.4M Sell
28,699
-4,465
-13% -$366K 0.08% 94
2021
Q1
$2.5M Sell
33,164
-1,371
-4% -$99.9K 0.1% 97
2020
Q4
$2.36M Sell
34,535
-4,102
-11% -$267K 0.1% 102
2020
Q3
$2.26M Sell
38,637
-2,016
-5% -$125K 0.11% 103
2020
Q2
$2.64M Sell
40,653
-3,476
-8% -$219K 0.14% 83
2020
Q1
$2.62M Buy
44,129
+593
+1% +$39.6K 0.19% 78
2019
Q4
$3.23M Buy
43,536
+16,546
+61% +$1.16M 0.37% 74
2019
Q3
$1.7M Sell
26,990
-3,359
-11% -$199K 0.22% 135
2019
Q2
$1.65M Buy
30,349
+1,197
+4% +$64.5K 0.2% 148
2019
Q1
$1.57M Sell
29,152
-3,257
-10% -$201K 0.21% 155
2018
Q4
$2.12M Buy
32,409
+9,767
+43% +$729K 0.29% 109
2018
Q3
$1.78M Sell
22,642
-447
-2% -$32K 0.21% 148
2018
Q2
$1.49M Buy
23,089
+991
+4% +$65.3K 0.18% 179
2018
Q1
$1.38M Sell
22,098
-973
-4% -$69.8K 0.18% 191
2017
Q4
$1.67M Sell
23,071
-1,122
-5% -$81.6K 0.21% 167
2017
Q3
$1.97M Sell
24,193
-440
-2% -$34.8K 0.25% 133
2017
Q2
$1.98M Buy
24,633
+1,038
+4% +$82K 0.26% 134
2017
Q1
$1.85M Sell
23,595
-1,468
-6% -$117K 0.26% 123
2016
Q4
$1.98M Sell
25,063
-10,860
-30% -$879K 0.28% 114
2016
Q3
$3.2M Sell
35,923
-11,014
-23% -$1.04M 0.47% 53
2016
Q2
$4.49M Sell
46,937
-1,653
-3% -$165K 0.62% 39
2016
Q1
$5.04M Sell
48,590
-1,470
-3% -$143K 0.66% 35
2015
Q4
$4.89M Sell
50,060
-1,182
-2% -$116K 0.62% 41
2015
Q3
$4.94M Sell
51,242
-1,303
-2% -$137K 0.66% 30
2015
Q2
$5.51M Sell
52,545
-6,502
-11% -$664K 0.67% 31
2015
Q1
$6.09M Sell
59,047
-6,252
-10% -$633K 0.67% 33
2014
Q4
$6.29M Sell
65,299
-3,614
-5% -$318K 0.62% 37
2014
Q3
$5.48M Sell
68,913
-1,883
-3% -$148K 0.54% 39
2014
Q2
$5.34M Buy
70,796
+368
+0.5% +$27.8K 0.51% 43
2014
Q1
$5.27M Sell
70,428
-5,946
-8% -$420K 0.51% 50
2013
Q4
$5.47M Sell
76,374
-4,234
-5% -$272K 0.49% 53
2013
Q3
$4.58M Sell
80,608
-3,076
-4% -$183K 0.43% 69
2013
Q2
$4.79M Buy
+83,684
New +$4.85M 0.46% 56

Other funds holding CVS

Sumitomo Life Insurance's CVS Position: Q1 2026 in Review

Sumitomo Life Insurance increased its CVS Health (CVS) stake by 2.8% in Q1 2026, buying an estimated $33.8K and bringing the position to 16,037 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #172.

Sumitomo Life Insurance first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.29M in Q4 2014. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Sumitomo Life Insurance held 16,037 shares of CVS Health worth $1.15M as of Q1 2026.
  • Sumitomo Life Insurance bought 439 CVS Health shares in Q1 2026, an estimated $33.8K.
  • CVS Health made up 0.03% of Sumitomo Life Insurance's portfolio in Q1 2026, its #172 holding.
  • Sumitomo Life Insurance first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Life Insurance's CVS Health position peaked at $6.29M in Q4 2014.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.